Evidence map›Paper›PMID 41330701›Full record

ReviewAllergy, asthma & immunology research2025

Update on Tree Nut and Seed Allergies: Prevalence, Clinical Characteristics, Diagnosis, and Management.

Kyunguk Jeong, Sooyoung Lee

Abstract readReview
In one paragraph

Review in Allergy, asthma & immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kyunguk JeongDepartment of Pediatrics, Ajou University School of Medicine, Suwon, Korea.ORCID https://orcid.org/0000-0002-1261-4507
Sooyoung LeeDepartment of Pediatrics, Ajou University School of Medicine, Suwon, Korea. jsjs87@ajou.ac.kr.ORCID https://orcid.org/0000-0003-1734-4101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tree nut (TN) and seed allergies have become increasingly recognized as important global health concerns, paralleling rising consumption driven by dietary trends. These allergies are often severe, typically develop in childhood, and may persist throughout life. Recent population-based studies show rising prevalence, particularly for TNs and sesame, with substantial regional variability. Clinical outcomes are strongly influenced by the underlying sensitization profile: storage proteins and lipid transfer proteins are associated with systemic reactions and anaphylaxis, whereas sensitization to pathogenesis-related group 10 and profilins usually results in milder manifestations including pollen-food syndrome. Co-sensitization among TNs and seeds occurs frequently; however, clinical co-allergy is observed to a lesser degree, with the highest overlap reported between cashew-pistachio and walnut-pecan. Advances in diagnosis, including component-resolved diagnostics and the basophil activation test, improve discrimination between clinical allergy and asymptomatic sensitization or mild localized reactions, and help minimize the need for oral food challenges. Acute management aligns with standard principles for immunoglobulin E-mediated food allergy, with prompt intramuscular epinephrine being the first-line treatment for anaphylaxis. Long-term management emphasizes accurate allergen identification, pragmatic dietary recommendation that supports inclusion of tolerated nuts, and preparedness with epinephrine for accidental exposure. Emerging data support the use of oral immunotherapy for selected TNs and sesame, with promising desensitization rates. Regulatory progress in allergen labeling and targeted education in high-risk settings, such as schools, restaurants, and air travel, are essential for prevention. Further studies are required to clarify natural history, to optimize immunotherapy, and to refine management for better supporting affected individuals across the lifespan.

Indexed as

allergensanaphylaxisco-sensitizationcross reactionsfood challengeimmunotherapylipid transfer proteinsNut hypersensitivitystorage proteins

Identifiers

PMID41330701
PMCPMC12683745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.